Description

Bevacizumab is a monoclonal antibody used in the treatment of various types of cancer by inhibiting angiogenesis, the formation of new blood vessels that tumors need to grow. It is commonly used for conditions such as colorectal cancer and non-small cell lung cancer.

Interpreter Notes

Interpreters should be aware that 'Bevacizumab' is often referred to by its brand name 'Avastin' in clinical settings. It is important to maintain a formal register and avoid colloquial terms. Ensure clarity when discussing treatment options involving this medication.

Example Sentences

EN: The oncologist prescribed Bevacizumab to help manage the patient's tumor growth.

ES: El oncólogo recetó Bevacizumab para ayudar a controlar el crecimiento del tumor del paciente.

Common Interpreter Mistakes

Confusing Bevacizumab with other monoclonal antibodies; mispronouncing Bevacizumab as if it were a different medication; using informal language when discussing treatment options.